Open Accessibility Menu
Outpatient Antibody Infusion

Outpatient Antibody Infusion

Outpatient Antibody Infusion Is Available at DCH for Eligible COVID-19 Positive Patients

The FDA has issued an Emergency Use Authorization for the Lilly product bamlanivimab and the Regeneron product casirivimab/imdevimab for treating of individuals who have tested positive for COVID-19 but have mild to moderate symptoms and are at risk of progressing to severe COVID-19 or hospitalization. This treatment is only available with a physician referral and is conducted in an outpatient setting to patients who do not require oxygen therapy due to COVID-19.

For COVID-19 positive adults, this treatment may be an option if you

  • are age 65 or older
  • have obesity, with a body mass index (BMI) of 35 or higher
  • have diabetes, chronic kidney disease, or a condition that weakens the immune system
  • take medication that weakens the immune system
  • are age 55 or older and have heart disease, high blood pressure, or a long-term lung disease

If you are currently positive with COVID-19 and think you may be a candidate for this therapy (based on the details above) then please contact your physician to discuss a potential referral.